Who
Chelsea Sierra Voss
Director
Company insider
Files Form 4 as: Director, Q/C Technologies.
In numbers
- Trades disclosed
- 10
- Buys
- 1
- Sells
- 0
- Bought
- $11K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 16 Jan 2026
- Last trade
- 13 Apr 2026
- Last filed
- 14 May 2026
Companies traded
Activity over time
1 Mar – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 13 Apr 2026filed 15 Apr 2026 | QCLS Q/C Technologiesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 13 Apr 2026filed 15 Apr 2026 | QCLS Q/C Technologiesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 30 Mar 2026filed 14 May 2026 | QCLS Q/C TechnologiesDiagnostics & Labs | SEC FORM 4 Bought | $5,5221,753 at $3.15 | filing |
| 30 Mar 2026filed 14 May 2026 | QCLS Q/C TechnologiesDiagnostics & Labs | SEC FORM 4 Bought | $5,5221,753 at $3.15 | filing |
| 16 Jan 2026filed 30 Jan 2026 | QCLS Q/C TechnologiesDiagnostics & Labs | SEC FORM 4 Code A | —212,500 at $0.00 | filing |
| 16 Jan 2026filed 30 Jan 2026 | QCLS Q/C TechnologiesDiagnostics & Labs | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 16 Jan 2026filed 30 Jan 2026 | QCLS Q/C Technologiesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —212,500 at $0.00 | filing |
| 16 Jan 2026filed 30 Jan 2026 | QCLS Q/C Technologiesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —212,500 at $0.00 | filing |
| 16 Jan 2026filed 30 Jan 2026 | QCLS Q/C TechnologiesDiagnostics & Labs | SEC FORM 4 Code A | —212,500 at $0.00 | filing |
| 16 Jan 2026filed 30 Jan 2026 | QCLS Q/C TechnologiesDiagnostics & Labs | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
News
Mymd Pharmaceuticals, Inc. (NASDAQ:QCLS) Shares Shorted: Short Interest Down 50.2% in SeptemberQCLS · dailypolitical.com · 17 Oct 2026
0 headlines in the last 90 days name Chelsea Sierra Voss; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.